SELENIUM: A NOUVELLE APPROACH FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: FARRAG, Nada (Misr International University, Clinical Pharmacy and Pharmacy Practice, Cairo, Egypt)
- Co-author(s): Nada Hazem Mohammed
Idiopathic pulmonary fibrosis (IPF), the common aggressive form of the interstitial pneumonias. It is chronic, progressive, irreversible and lethal lung disease with a poor prognosis.
The current study is a prospective, randomized comparative study. Eligible patients were randomly assigned to either group A; 20 patients received oral Selenium 200 µ.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.